The Sad Truth
Alzheimer’s and dementia-related illnesses are leading causes of death in the United States. Instead of moving closer to a cure, we are moving closer to the disease with a new person being diagnosed every 65 seconds.
Alzheimer’s is the only top-10 cause of death in the United States with NO cure, means of prevention, or treatment to modify the disease. Approximately 5.7 million people in the U.S. currently have Alzheimer’s disease or a dementia-related illness. The number of Americans with Alzheimer’s is projected to triple to 16 million by 2050.
A cure needs to be identified. NOW!
IN ASSOCIATION WITH
UNIVERSITY OF SOUTHERN CALIFORNIA ALZHEIMER’S DISEASE RESEARCH CENTER (ADRC) is one of 30 sites across the United States studying memory and aging, as well as Alzheimer’s disease. The ADRC provides participants with access to leading-edge studies of new medications and treatment that advance our knowledge of memory problems associated with aging. Over the past 30 years, USC physicians and researchers have made major contributions to our knowledge of Alzheimer’s disease, vascular risk factors, and memory problems. Our Staff includes neurologist, psychiatrists, psychologists, physician assistants, nurses, and social workers who collaborate with basic scientists on diagnosis, treatment and research.
We’re the University of South Alabama. South, for short. Home to nearly 14,000 students and more than 125 academic programs, South is a dynamic community of leaders and learners who support and challenge one another to be actively engaged citizens who advance the Gulf Coast region and the world. The faculty and medical scholars at the University of South Alabama have created an environment that supports curiosity and discovery. USA researchers are problem-solvers and pioneers in developing new technologies and promoting bold ideas, and faculty often collaborate across disciplines to address issues and uncover new fields of inquiry. The outcomes are high-quality research and scholarship, new information and opportunities, the transformation of traditional disciplines, new global partnerships, and innovations that benefit society.
At UC San Francisco, we are driven by the idea that when the best research, the best teaching and the best patient care converge, we can deliver breakthroughs that help heal the world. The UCSF Memory and Aging Center is an NIA-designated Alzheimer’s Disease Research Center working to translate research science into improved diagnosis and care for people with dementia due to Alzheimer's disease and related diseases, as well as to find a treatment or prevention.
Current Donor Options
“I would like to sincerely thank AlzOut for donating to my lab to help purchase equipment, namely a ‘MESO QuickPlex SQ 120’, to measure biomarkers of Alzheimer’s disease. Alzheimer’s disease steals the minds of millions and robs time from families with their loved ones. This equipment will aid greatly in helping us determine root causes of Alzheimer’s disease and ways to prevent AD in the future.”
“I would like to give a special acknowledgement to Johnny Weir for selflessly raising funds for AlzOut. I was a competitive figure skater from childhood through my late teens, so I am honored and excited to think that he has made an indirect contribution to our Alzheimer’s research!”
“As an early career investigator in the field of Exercise Physiology, I am incredibly thankful for the financial support from AlzOut to purchase a state-of-the-art multiplex. It is truly my belief that exercise is medicine and that physical activity can play a significant role in delaying, if not preventing, the onset of numerous diseases including Alzheimer’s and related dementias. Adding the multiplex instrument to our tool kit has allowed us to ask more in-depth questions as well as to seek mechanistic links between exercise and age-related cognitive decline. With these newly garnered abilities, I am most excited to contribute to the currently known findings pertaining to exercise and brain health, especially in populations that have been historically excluded from prominent biomedical research trials. Therefore, the contribution of AlzOut has not only accentuated our research capabilities, but ultimately, they have extended our reach into our communities, which will undoubtedly translate into a lasting impact.”
“Thank you, AlzOut, for helping to fund our lab’s purchase of a multiplex instrument! This equipment will allow us to investigate biomarker changes in Alzheimer’s disease biofluids such as plasma and cerebrospinal fluid.”
“The Nelson lab is so grateful for AlzOut’s generous donation, which equipped the lab with a plate reader necessary to measure key biomarkers of Alzheimer’s disease. Your donation will ultimately support cutting-edge efforts to understand how Alzheimer’s disease develops and how to more effectively treat the causes and symptoms of this widespread disease affecting more than 6 million Americans. Furthermore, this plate reader will allow us to collaborate on projects outside of our lab, increasing awareness of our research and Alzheimer’s in the scientific community. Without support like yours, further understanding Alzheimer’s disease would not be possible, so we would like to thank you again for your support of our research that could benefit millions.”
“On behalf of the entire Nelson Lab, we want to sincerely thank AlzOut for their donation to our lab. We are primarily focused on determining causes of Alzheimer’s disease. With the funding generously provided by AlzOut, we purchased a MESO QuickPlex SQ 120. This multiplex plate reader will allow us to measure proteins such as amyloid-beta and tau as well as proinflammatory cytokines and other molecules associated with Alzheimer’s disease. We are incredibly thankful for AlzOut’s financial support for this important work.”
“We’re extremely thankful to AlzOut for their donation to the Nelson Lab! With the donation, we purchased a MESO QuickPlex SQ 120. This device will let us measure amyloid-beta, tau, proinflammatory cytokines, and other biomarkers linked to Alzheimer’s disease, providing data necessary to determine if an association between these biomarkers and infections exists.”
Latest News
AlzOut Researchers Gain National Recognition
Amy R. Nelson, Ph.D., has devoted more than a decade to researching Alzheimer’s disease, educating
Alzheimer’s and Covid 19: Virtual Town Hall
AlzOut and Dr. Hussein Yassine, a leading researcher at Keck Medicine of USC, explore the
ALZOUT Donates to the Yassine Lab
We are very thankful for ALZOUT for their support of the Yassine Lab. In 2019,
For Nana: Fighting to End Alzheimer’s One Music Note at a Time
Tonight, on June 21, 2018, my team is hosting our first-ever benefit concert and cocktail